LINCS MCF 10A Common Project: Rolling-time-point sensitivity measures of the MCF 10A breast cell line to 8 small molecule perturbagens. Dataset 1 of 15: End-point cell counts and normalized growth rate inhibition values for all technical replicates of biological replicate 1. - Dataset (ID:20309)
Download: Excel (XLSX), Comma-separated (CSV)
| Cell | Small Molecule | Small Mol Concentration (uM) | Time Point (hr) | Total Cell Count Before Treatment | Total Cell Count After Treatment | Total Control Cell Count | Relative Cell Count | Normalized Growth Rate Inhibition Value | Assay Plate | Assay Well |
|---|---|---|---|---|---|---|---|---|---|---|
| MCF 10A-H2B-mCherry | Alpelisib | 10 | 85.64 | 770.25 | 6110 | 12287 | 0.4973 | 0.6792 | MN20160304_L02 | N07 |
| MCF 10A-H2B-mCherry | Alpelisib | 10 | 87.86 | 770.25 | 6744 | 12543 | 0.5377 | 0.7143 | MN20160304_L02 | C21 |
| MCF 10A-H2B-mCherry | Alpelisib | 10 | 87.86 | 770.25 | 8586 | 12543 | 0.6845 | 0.8203 | MN20160304_L02 | D19 |
| MCF 10A-H2B-mCherry | Alpelisib | 10 | 87.86 | 770.25 | 8142 | 12543 | 0.6491 | 0.7964 | MN20160304_L02 | G20 |
| MCF 10A-H2B-mCherry | Alpelisib | 10 | 87.86 | 770.25 | 8745 | 12543 | 0.6972 | 0.8286 | MN20160304_L02 | J10 |
| MCF 10A-H2B-mCherry | Alpelisib | 10 | 87.86 | 770.25 | 6107 | 12543 | 0.4869 | 0.6725 | MN20160304_L02 | N07 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.0010833 | 3.21 | 770.25 | 1032 | 904 | 1.1408 | 2.5289 | MN20160304_L02 | L17 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.0010833 | 3.21 | 770.25 | 959 | 904 | 1.0601 | 1.5722 | MN20160304_L02 | N15 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.0010833 | 5.44 | 770.25 | 1166 | 1012 | 1.1513 | 1.8576 | MN20160304_L02 | L17 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.0010833 | 5.44 | 770.25 | 1064 | 1012 | 1.0506 | 1.2663 | MN20160304_L02 | N15 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.0010833 | 7.66 | 770.25 | 1271 | 1090 | 1.1661 | 1.7178 | MN20160304_L02 | L17 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.0010833 | 7.66 | 770.25 | 1146 | 1090 | 1.0514 | 1.2104 | MN20160304_L02 | N15 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.0010833 | 10.06 | 770.25 | 1409 | 1218 | 1.1563 | 1.4910 | MN20160304_L02 | L17 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.0010833 | 10.06 | 770.25 | 1270 | 1218 | 1.0423 | 1.1291 | MN20160304_L02 | N15 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.0010833 | 12.28 | 770.25 | 1555 | 1358 | 1.1450 | 1.3598 | MN20160304_L02 | L17 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.0010833 | 12.28 | 770.25 | 1407 | 1358 | 1.0360 | 1.0883 | MN20160304_L02 | N15 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.0010833 | 14.50 | 770.25 | 1774 | 1497 | 1.1848 | 1.3870 | MN20160304_L02 | L17 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.0010833 | 14.50 | 770.25 | 1616 | 1497 | 1.0793 | 1.1657 | MN20160304_L02 | N15 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.0010833 | 16.73 | 770.25 | 1960 | 1664 | 1.1775 | 1.3167 | MN20160304_L02 | L17 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.0010833 | 16.73 | 770.25 | 1808 | 1664 | 1.0862 | 1.1544 | MN20160304_L02 | N15 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.0010833 | 18.95 | 770.25 | 2144 | 1832 | 1.1700 | 1.2675 | MN20160304_L02 | L17 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.0010833 | 18.95 | 770.25 | 1984 | 1832 | 1.0827 | 1.1312 | MN20160304_L02 | N15 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.0010833 | 21.17 | 770.25 | 2348 | 2008 | 1.1691 | 1.2393 | MN20160304_L02 | L17 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.0010833 | 21.17 | 770.25 | 2183 | 2008 | 1.0869 | 1.1243 | MN20160304_L02 | N15 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.0010833 | 23.39 | 770.25 | 2589 | 2244 | 1.1535 | 1.1939 | MN20160304_L02 | L17 |